Over Two Decades of Prostate Cancer Care Build Expertise, Innovation
Duke Cancer Institute Center for Prostate and Urologic Cancers has embraced multidisciplinary care for over 20 years.
Related Articles
Can WHOβs new trials guidance challenge a lack of inclusivity in research?
The World Health Organization wants to tackle inequity and bureaucracy relating to clinical trials. Will its latest guidance make a difference? Anna Volkmer reports During…
Elon Muskβs Business Empire Scores Benefits Under Trump Shake-Up
Government investigations into Mr. Muskβs companies are stalling from President Trumpβs firings and Biden administration resignations.
2025 Spring Scientific
The 2025 SITC Spring Scientific, Cellular Therapy for Solid Tumors, will address the recent advances in adoptive cellular therapy for solid tumors and rate-limiting challenges…
RLR From The Clinical Problem Solvers β The Clinical Problem Solvers
Diagnosis is one of the most important clinical skills. You cannot treat a patient or provide a prognosis without the right diagnosis. You can unsubscribe…
2025 FASCO Recipients Part β 2 – OncoDaily
2025 FASCO Recipients Part β 2 / Amy C. Peterson, Anne S. Tsao, ASCO, cancer, Claudine Isaacs, Dana-Farber Cancer Institute, FASCO, Fellow of the American
Year in Review: Clinical Investigator Perspectives on the Most Relevant New Datasets and Advances in Oncology | Research To Practice
LIVE WEBINAR: Wednesday, February 19, 2025 | 5:00 PM β 6:00 PM Eastern Time (ET) Register for this complimentary event with the βRegister Nowβ button…
Maternal Anti-PF4 Antibodies as Cause of Neonatal Stroke | NEJM
Maternal platelet-activating antiβplatelet factor 4 antibodies led to cerebral venous sinus thrombosis, thrombocytopenia, hyperfibrinolysis, and cerebral bleeding in a neonate.
Pete Hegseth booed and heckled in Germany by military families protesting anti-DEI push
Military families protesting the defense department’s anti-DEI push heckled Defense Secretary Hegseth at United States European Command headquarters in Germany.